The initiative, which will start with monoclonal antibodies, is the first big regulatory shift from the FDA since Martin ...

The bispecific antibody helped people with small cell lung cancer live longer, Amgen said. Elsewhere, J&J shared new autoimmune drug data and Alzheon reported an Alzheimer’s drug failure.

Experts say the layoffs are already causing issues in drug development — and things may get far worse without critical ...

Novartis’ expansion will substantially boost its capital spending, which has run around $1 billion the past several years. It will also broaden Novartis’ commercial footprint, adding six new ...

Drug company shares, which had sunk on comments by Trump that pharma duties would be coming soon, rallied along with the broader market.

In its first full year on the U.S. market, bladder cancer treatment Adstiladrin earned about $77 million. Elsewhere, Lilly ...

Shares in many large drugmakers initially fell Wednesday on the president's threat, only to rebound later when he announced a ...